A surprise complete response letter for Recro Pharma has promptly wiped away half the company’s market value. Cosmo Pharmaceuticals, which yesterday confirmed a similar fate with its lead project, has likewise suffered a stock market rout.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,